Clinical Trial: Effects of Concurrent Training on Serum PCSK9 Levels in Adults With Overweight

U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07910916) titled 'Effects of Concurrent Training on Serum PCSK9 Levels in Adults With Overweight' on Oct. 27.

Brief Summary: Being overweight can increase the risk of heart disease. PCSK9 is a protein that helps regulate cholesterol levels in the blood. Exercise may affect PCSK9 levels, but previous studies have reported conflicting results.

The purpose of this study is to determine whether a program combining aerobic exercise and resistance training changes blood PCSK9 levels in adults with overweight. The researchers will also examine changes in blood cholesterol levels and body composition.

A total of 42 adults aged 18-40 years with overweight wi...